Pediatrix Medical Group (MD) Proxy filing summary

Executive summary

• The annual meeting is scheduled for May 7, 2026, with shareholders invited to vote on director nominees and other proposals.

• The Board unanimously recommends voting "FOR" all nine director nominees.

• ISS and Glass Lewis recommend voting "FOR" eight nominees and all other proposals, but advise against re-electing John M. Starcher, Jr. due to attendance.

Voting matters and shareholder proposals

• Shareholders are asked to vote on the election of nine directors and other proposals outlined in the proxy statement.

• Proxy advisory firms support all proposals and eight nominees, with a single exception based on attendance.

Board of directors and corporate governance

• John M. Starcher, Jr. is highlighted for his healthcare leadership and strategic expertise.

• Starcher attended 73% of meetings in 2025 due to a scheduling conflict, but has a strong attendance record overall.

• The Board and management remain supportive of Starcher, noting his full attendance in 2026.